SUPPLEMENTAL FINANCIAL INFORMATION FOR THREE MONTHS ENDED SEPTEMBER 30, 2025 November 6, 2025 60 Cutter Mill Rd., Great Neck, NY 11021 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS Exhibit 99.1 We consider some of the information set forth herein to contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, with respect to our expect ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION American Coastal Insurance Corporation (Exact Name of Registrant as Specified in its Charter) WASHINGTON, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-35761 (State or Other J ...

Exhibit 99.1 -- Continued Improvements in Efficiency and Productivity Across the Organization -- Conference Call Today at 4:30pm ET CHASKA, Minn., November 6, 2025 -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organization ("CDMO"), today announced its financial results for the three months ended September 30, 2025. Lifecore Biomedical Reports Financial Results for the Three Months Ended September 30, 2025, and Provides Corporate Update - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number 001-35761 American Coastal Insurance Corporation (Exact Name of Registrant as Specified in its Charter) (State or Other J ...

Financial Performance - Q3 2025 revenue was $364.2 million, a decrease of 15.3% year-over-year, or 11.5% excluding Mavely 2024 revenue[3] - Earnings per share (EPS) increased to $0.34 compared to $0.17 in the prior year[3] - Q4 2025 revenue guidance is projected between $365 million and $400 million, reflecting a decline of 18% to 10% year-over-year[6] - Full-year 2025 revenue is expected to be between $1.48 billion and $1.51 billion, a decrease of 15% to 13% year-over-year[7] - Total revenue for the three months ended September 30, 2025, was $364,211, a decrease of 15.3% compared to $430,145 in the same period of 2024[21] - Net income for the three months ended September 30, 2025, was $17,079, compared to $8,302 in Q3 2024, reflecting a positive growth trend[21] - The forecasted revenue for 2025 is projected to be between $1,479,839 and $1,514,839, indicating a cautious outlook for the upcoming year[27] Customer Metrics - Customer count decreased by 10% to 746,256, while paid affiliates and sales leaders decreased by 13% and 19%, respectively[3] - Total customers decreased by 10% to 746,256 in Q3 2025 from 831,768 in Q3 2024, with significant declines in Mainland China (29%) and Southeast Asia/Pacific (13%)[19] - Total paid affiliates decreased by 13% to 130,096 in Q3 2025 from 149,264 in Q3 2024, indicating a decline in the sales force[19] Profitability and Margins - Gross margin improved to 70.5% from 70.1%, with operating margin increasing to 5.9% from 4.2%[5] - The company reported a gross profit of $256,723 for Q3 2025, down from $301,463 in Q3 2024, resulting in a gross margin of approximately 70.5%[21] - Operating income for the nine months ended September 30, 2025, was $42,519, a significant improvement from a loss of $98,504 in the same period of 2024[21] - Adjusted earnings per share for 2025 are expected to be between $1.25 and $1.35, excluding the impact of certain charges and gains[26] Cash Flow and Financial Health - The company reported $3.0 million in dividend payments and $5.0 million in stock repurchases during the quarter[6] - The company’s cash and cash equivalents increased to $251,787 as of September 30, 2025, from $186,883 at the end of December 2024[23] - The company’s total liabilities decreased to $624,611 as of September 30, 2025, from $817,459 at the end of December 2024, reflecting improved financial health[23] Future Plans and Developments - The company plans to introduce the Prysm iO intelligent wellness platform in late Q4 2025, with a full consumer launch expected in 2026[4] - The company is preparing for pre-market opening activities in India, with a formal launch planned for the second half of 2026[4] Regional Performance - Latin America region showed strong double-digit year-over-year growth, indicating positive trends in certain segments[3]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-36912 CIDARA THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorpora ...

Phunware Reports Third Quarter 2025 Financial Results Consistent Product Revenue, Customer Momentum and Strong Liquidity Positioning the Company for New AI Technology Integration and Corporate Initiatives AUSTIN, Texas – November 6, 2025 – Phunware, Inc. ("Phunware", or the "Company") (NASDAQ: PHUN), the enterprise cloud platform for mobile that provides products, solutions, data, and services for brands to engage, manage and monetize global audiences, today reported financial results for the third quarter ...

Washington, D.C. 20549 _____________________________ FORM 10-Q _____________________________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11356 _______________________________ Radian Group Inc. (Exact nam ...

Third Quarter 2025 Highlights a Exhibit 99.1 Willdan Group Reports Third Quarter Results ANAHEIM, Calif. –November 6, 2025 – Willdan Group, Inc. ("Willdan") (Nasdaq: WLDN) today announced its financial results for the third quarter ended October 3, 2025. Assumes 15.2 million diluted shares, 10% effective tax rate benefit, and no future acquisitions. a. As compared to the same period of fiscal year 2024. b. See "Use of Non-GAAP Financial Measures" below. c. These updated financial targets supersede any previ ...

Exhibit 99.1 SAUL CENTERS, INC. 7501 Wisconsin Avenue, Suite 1500E, Bethesda, Maryland 20814-6522 (301) 986-6200 Saul Centers, Inc. Reports Third Quarter 2025 Earnings November 6, 2025, Bethesda, MD. Saul Centers, Inc. (NYSE: BFS) (the "Company"), an equity real estate investment trust ("REIT"), announced operating results for the quarter ended September 30, 2025 ("2025 Quarter"). Total revenue for the 2025 Quarter increased to $72.0 million from $67.3 million for the quarter ended September 30, 2024 ("2024 ...